WO2024042324A1 - Système et procédé de surveillance d'administration de médicament - Google Patents

Système et procédé de surveillance d'administration de médicament Download PDF

Info

Publication number
WO2024042324A1
WO2024042324A1 PCT/GB2023/052196 GB2023052196W WO2024042324A1 WO 2024042324 A1 WO2024042324 A1 WO 2024042324A1 GB 2023052196 W GB2023052196 W GB 2023052196W WO 2024042324 A1 WO2024042324 A1 WO 2024042324A1
Authority
WO
WIPO (PCT)
Prior art keywords
drug delivery
delivery device
state
drug
determined
Prior art date
Application number
PCT/GB2023/052196
Other languages
English (en)
Inventor
Mark Robson Humphries
Kate HUDSON-FARMER
Simon Hall
Mayur Patel
Original Assignee
Pa Knowledge Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pa Knowledge Limited filed Critical Pa Knowledge Limited
Publication of WO2024042324A1 publication Critical patent/WO2024042324A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G16H20/17—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients delivered via infusion or injection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
    • A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
    • A61B5/0013—Medical image data
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/31568—Means keeping track of the total dose administered, e.g. since the cartridge was inserted
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31565—Administration mechanisms, i.e. constructional features, modes of administering a dose
    • A61M5/31566—Means improving security or handling thereof
    • A61M5/3157—Means providing feedback signals when administration is completed
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H40/00—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices
    • G16H40/60—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices
    • G16H40/63—ICT specially adapted for the management or administration of healthcare resources or facilities; ICT specially adapted for the management or operation of medical equipment or devices for the operation of medical equipment or devices for local operation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3125—Details specific display means, e.g. to indicate dose setting
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3125—Details specific display means, e.g. to indicate dose setting
    • A61M2005/3126—Specific display means related to dosing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/502—User interfaces, e.g. screens or keyboards
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/50—General characteristics of the apparatus with microprocessors or computers
    • A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/58—Means for facilitating use, e.g. by people with impaired vision
    • A61M2205/583—Means for facilitating use, e.g. by people with impaired vision by visual feedback
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2209/00—Ancillary equipment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/20—Automatic syringes, e.g. with automatically actuated piston rod, with automatic needle injection, filling automatically

Definitions

  • the present disclosure relates to a system and method for monitoring delivery of a drug to a subject by a drug delivery device.
  • Drug delivery devices particularly those that inject a drug into a patient, are often used by people without medical training, e.g. self-administering a drug or administering a drug to another person in their care. This can result in ineffective or incomplete drug delivery.
  • Auto-injectors are one example of such drug delivery devices, and are specifically designed for untrained users. However, even these devices may be misused, for example a user may lift the device too early such that only a partial dose is administered.
  • the present disclosure aims to at least partially solve the above problems.
  • a system for monitoring delivery of a drug to a subject by a drug delivery device comprising: a data capture device, separate from the drug delivery device, configured to obtain sensory data about the drug delivery device, when the drug delivery device is in use; a processor configured to process the sensory data to determine a state of the drug delivery device.
  • the processor is configured to further compare the determined state of the drug delivery device to a desired state.
  • the processor is configured to determine an action to be taken to change the determined state to the desired state.
  • the system comprises a user interface configured to communicate information relating to the desired state and/or determined action to a user of the drug delivery device.
  • the user interface comprises a screen configured to display a real-time image of the drug delivery device with the information relating to the desired state and/or determine action visually overlaid.
  • the desired state is a next state in a predetermined sequence of states.
  • the predetermined sequence of states depends on the type of drug delivery device determined by the processor.
  • the processor is configured to continuously re-determine of the state of the drug delivery device.
  • the processor is configured to continuously re-determine of the state of the drug delivery device until a desired end state is determined.
  • the drug delivery device is an auto -injector.
  • the state of the drug delivery device comprises the orientation of the drug delivery device determined based on image data.
  • the orientation comprises an angle formed by the drug delivery device with a reference surface separate from the drug delivery device.
  • the reference surface is part of the subject.
  • the orientation comprise an angle formed by the drug delivery device with the data capture device.
  • the state of the drug delivery device comprises initiation of drug delivery by the drug delivery device.
  • the initiation of drug delivery is determined based on image data and/or acoustic data.
  • the state of the drug delivery device comprises an end of drug delivery by the drug delivery device.
  • the end of drug delivery is determined based on image data.
  • the end of drug delivery is determined based on acoustic data.
  • the state of the drug delivery device comprises an amount of a drug within the drug delivery device or delivered by the drug delivery device.
  • the processor is configured to determine the position of at least a portion of a mechanical dispensing means of the drug delivery device in order to determine an amount of a drug within the drug delivery device or delivered by the drug delivery device, the mechanical dispensing means being configured to move to dispense the drug.
  • the state of the drug delivery device comprises a rate of delivery of a drug by the drug delivery device.
  • the processor is configured to determine the rate of change in position of at least a portion of a mechanical dispensing means of the drug delivery device to determine the rate of delivery of a drug by the drug delivery device, the mechanical dispensing means being configured to move to dispense the drug.
  • the state of the drug delivery device comprises the location of the drug delivery device relative to a reference location separate from the drug delivery device.
  • the reference location is part of the subject.
  • the state is an angle formed by the drug delivery device with a reference surface separate from the drug delivery device and the desired state is an angle substantially perpendicular to the reference surface.
  • the processor is configured to determine the desired state based on image data of the reference surface.
  • the state is an orientation of the device and the desired orientation is an orientation in which a specific part of the drug delivery device is visible by the data capture device.
  • the processor is configured to determine the desired state based on prestored data relating to the type of drug delivery device.
  • the specific part of the drug delivery device is a mechanical dispensing means of the drug delivery device, the mechanical dispensing means being configured to move to deliver the drug.
  • the processor is configured to determine the type of drug delivery device and further process the sensory data based on the type of drug delivery device.
  • the type of drug delivery device is determined based on image data of the drug delivery device obtained by the data capture device.
  • the type of drug delivery device is determined based on the shape of the drug delivery device, or a part thereof, determined from the image data.
  • the type of drug delivery device is determined based on a visual encoded data within the image data.
  • the visual encoded data is a character string, a barcode or a QR code.
  • the data capture device comprises one of a smartphone and a tablet computer.
  • a method ot monitoring delivery of a drug to a subject by a drug delivery device comprising: obtaining sensory data about the drug delivery device using a data capture device separate from the drug delivery device, when the drug delivery device is in use; processing the sensory data to determine a state of the drug delivery device.
  • the method further comprises comparing the determined state of the drug delivery device to a desired state.
  • the method further comprises determining an action to be taken to change the determined state to the desired state.
  • the method further comprises communicating information relating to the desired state and/or determined action to a user of the drug delivery device.
  • the user interface comprises a screen configured to display a real-time image of the drug delivery device with the information relating to the desired state and/or determine action visually overlaid.
  • the desired state is a next state in a predetermined sequence of states.
  • the predetermined sequence of states depends on the type of drug delivery device determined by the processor.
  • the method comprises continuously re-determine of the state of the drug delivery device.
  • the method comprises continuously re-determine of the state of the drug delivery device until a desired end state is determined.
  • Fig. 1 shows an example system according to the disclosure
  • Fig. 2 shows an example identifier of drug delivery device type
  • Fig. 3 shows example displays of a user interface of the example system
  • Fig. 4 is a flow chart of an example process according to the disclosure.
  • Fig. 1 shows an example system for monitoring delivery of a drug to a subject 2 by a drug delivery device 1.
  • the drug delivery device 1 may be an auto-injector.
  • the drug delivery device 1 may therefore comprise a casing housing a syringe, the casing comprising an opening in one end through which the syringe can be deployed.
  • the device 1 may also comprise a cap for covering the opening.
  • the syringe may comprise a needle, a reservoir comprising a liquid comprising the drug and a mechanical dispensing means, such as a plunger for ejecting the liquid.
  • the device 1 may further comprise an injection mechanism housed within the casing and configured to deploy the syringe, e.g. into a subject, and deliver the liquid, e.g. by actuating the mechanical dispensing means.
  • the injection mechanism may be initiated by pressing a button.
  • the casing may comprise a window for viewing the reservoir of the syringe.
  • different drug delivery devices may be used, e.g. a syringe, a prefilled syringe or a vial and syringe; a pen injector, an injector pump, an ambulatory injection device or a wearable injection device.
  • the drug delivery device may alternatively comprise means for reconstituting a solid drug (e.g. in powder form, such as a lyophilized drug) with a liquid dispensing medium, such as water, prior to dispensing.
  • a reconstitution drug delivery device is known as a reconstitution drug delivery device.
  • the example system comprises a data capture device 3, separate from the drug delivery device 1 , configured to obtain sensory data about the drug delivery device 1, when the drug delivery device 1 is in use.
  • the data capture device 3 may be a smart phone, as shown in Fig. 1.
  • the data capture device may be a tablet computer, or other type of hand-held device.
  • a user may hold the device in use, but may alternatively use a holder (e.g. a stand-alone holder also separate from the drug delivery device 1), such as a tripod or similar device, or mounted/worn on the body, or prop the device up.
  • the data capture device 3 is configured to obtain sensory data about the drug delivery device 1, when separated from the drug delivery device 1. In other words, the data capture device 3 may remain separated from the drug delivery device 1 in use. This is in contrast to some known “add-on” devices that attach to a drug delivery device, in use.
  • the data capture device 3 may be configured to obtain sensory data about the drug delivery device 1 including image data.
  • Image data may be obtained using a camera forming part of the data capture device 3.
  • the data capture device may be configured to obtain video image data.
  • the video image data may comprise a plurality of image frames obtained at a predefined frame rate. Alternatively, single or multiple still images may be used.
  • the data capture device 3 is a smartphone or tablet computer, for example, which has front and back cameras, one or both of these cameras may be used to capture image data. This may enable the user to use the data capture device 3 in a number of different positions and with different orientations. This may allow the user to view a screen provided to the data capture device 3, as described below.
  • the data capture device 3 may also be configured to obtain electromagnetic data, such as NFC data, e.g. via an NFC module forming part of the data capture device 3.
  • the data capture device 3 may alternatively or additionally obtain acoustic data, e.g. via a microphone forming part of the data capture device 3.
  • the example system further comprises a processor configured to process the sensory data to determine a state of the drug delivery device 1.
  • the processor may form part of the data capture device 3.
  • the processor may be separate from the data capture device 3, for example the processor may form part of a remote server.
  • multiple processors may be used, with at least one processor forming part of the data capture device 3 and at least one processor being separate from the data capture device 3. If a processor separate from the data capture device is used, the data capture device 3 and the processor may comprise means for communicating data, either via a wiretess or wired data connection.
  • the state of the drug delivery device 1 may relate to a specific configuration of the drug delivery device 1 during use.
  • the state may be one of a predefined group of possible states. As in the example described, the state may form part of a sequence of states that the drug delivery device 1 may have during use.
  • the determined state of the drug delivery device 1 may indicate whether the drug delivery device is operating, or being operated, correctly or incorrectly.
  • Predefined possible states may be based on the type of drug delivery device 1 and/or the type of drug.
  • the processor may be configured to determine the type of drug delivery device 1 and further process the sensory data based on the type of drug delivery device 1.
  • the type of drug delivery device 1 and/or the type of drug may be determined based on image data of the drug delivery device 1.
  • the type of drug delivery device 1 and/or the type of drug may be determined based on the shape of the drug delivery device 1, or a part thereof, determined from the image data.
  • the type of drug delivery device 1 and/or the type of drug may be determined based on a visual encoded data within the image data.
  • the visual encoded data may be a character string, a barcode or a QR code 11, as shown in Fig 2.
  • the type of drug delivery device 1 and/or the type of drug may be determined based on electromagnetic data, such as NFC data from an NFC tag of the drug delivery device 1.
  • the processor may execute a machine learning algorithm trained to recognise the type of drug delivery device 1 and/or the type of drug.
  • the processor may perform standard image processing that identifies specific aspects of an image indicative of the type of drug delivery device 1 and/or the type of drug.
  • the processor may be configured to determine (or re-determine) the state of the drug delivery device 1 continuously, e.g. at predefined intervals.
  • the processor may be configured to compare the determined state of the drug delivery device 1 to a desired state.
  • the desired state of the drug delivery device 1 may be determined based on the determined state of the drug delivery device 1.
  • the desired state may be a next state in a predefined sequence of states. If the determined state of the drug delivery device 1 does not change (e.g. within a predefined time period) or changes to a different state that is not the desired state, then it may be determined that the drug delivery device 1 is operating, or being operated, incorrectly.
  • the user and/or a clinician may be alerted.
  • the alert may communicate details of the incorrect operation.
  • the processor may alert the user via a user interface as described below.
  • the processor may alert a clinician by sending an electronic message, e.g. via a wireless communication module forming part of the data capture device 3. In such as case, processing may be brought to an end.
  • the determined state of the device 1 changes to the desired state (e.g. within a predefined time period)
  • the desired state may also change. For example, if the desired state is a next state in a sequence, as a desired state is reached, the next desired state may be the next state in the sequence. This process may continue until an end state is determined by the processor.
  • the processor may be configured to determine an action to be taken (e.g. by a user of the device 1) to change the determined state to the desired state.
  • the action may be determined based on the determined state of the drug delivery device 1 and/or the desired state (e.g. based on the type of drug delivery device 1).
  • Information relating to the desired state and/or determined action may be communicated to a user of the drug delivery device 1. This information may provide the user with instructions to take the determined action.
  • the system may comprise a user interface configured to communicate the information relating to the desired state and/or the determined action, to a user of the drug delivery device 1.
  • the user interface may comprise a screen 30, e.g. forming part of the data capture device 3. This may be the inbuild screen of a smartphone or tablet computer, for example.
  • the screen 30 may be configured to display a real-time image 31 of the drug delivery device 1 with the information 32, 33 relating to the desired state and/or determined action visually overlaid.
  • the information may comprise images 32 and/or text instructions 33.
  • the images may comprise augmented reality images.
  • the information may alternatively or additionally be communication via audio.
  • the user interface may comprise a speaker, e.g. forming part of the data capture device 3.
  • the user interface may alternatively or additionally provide haptic feedback, e.g. in the form of vibrations, for example when a desired state is reached.
  • Fig. 4 is flow chart showing example processing performed by the processor.
  • step S4.1 an initial state of the drug delivery device 1 is determined.
  • step S4.2 instructions for reaching the next state (desired state) are overlaid on a real-time image 31 of the drug delivery device 1 on the screen 30.
  • step S4.3 the state of the drug delivery device 1 is re-determined.
  • step S4.4 the state is compared to the next state. If the next state has not yet been reached, a counter in incremented at step S4.5, and if the counter reaches a threshold at step S4.6, an error message may be displayed on the screen 30 at step S4.7. If the threshold is not reached the process returns to step S4.3.
  • step S4.4 the next state has been reached, it is determined whether the state is an end state at step S4.8. If the next state is not an end state the process returns to step S4.2 and the instructions for the new state are overlaid on a real-time image 31 of the drug delivery device 1 on the screen 30. If the next state is an end state, the processing ends.
  • the state of the drug delivery device 1 may relate to one or more of: priming of the drug delivery device 1, reconstitution of the drug in a reconstitution drug delivery device 1, location of the drug delivery device 1, orientation of the drug delivery device 1, initiation of drug delivery by the drug delivery device 1 , rate of drug delivery by the drug delivery device 1, amount of drug delivered by the drug delivery device 1, temperature of the drug delivered by the drug delivery device 1, interruption of drug delivery by the drug delivery device 1, and end of drug delivery by the drug delivery device 1.
  • Priming of the drug delivery device 1 may relate to removal of a cap from the drug delivery device 1.
  • the processor may be configured to process images to determine the presence or absence of a cap. As shown in Fig. 3 if it is determined that the drug delivery device 1 is in a state in which the cap is on, instructions to remove the cap may be communicated of the user. This may include displaying an augmented reality image ot tne cap of the drug delivery device 1 in a real-time displayed image of the drug delivery device 1.
  • the processor may be configured to process images to determine whether the drug has correctly reconstituted in the drug delivery device, e.g. from an image of a window showing the drug and/or liquid to be dispensed.
  • Location of the drug delivery device may relate to the location of the drug delivery device 1 relative to a reference location separate from the drug delivery device 1.
  • the reference location may be part of the subject, e.g. an injection site.
  • the processor may be configured to process images to determine whether the drug delivery device 1 is at the reference location.
  • the reference location may also be determined by the processor based on image data. As shown in Fig. 3, if it is determined that the drug delivery device 1 is in a state in which it is not at the reference location, instructions to move it to the reference location may be communicated to the user. This may include displaying an augmented reality image of the reference location in in a real-time displayed image of the drug delivery device 1.
  • Orientation of the drug delivery device 1 may relate to an angle formed by the drug delivery device 1 with a reference surface separate from the drug delivery device 1.
  • the reference surface may be part of the subject, e.g. an injection site.
  • the processor may be configured to process images to determine whether the drug delivery device 1 has a desired orientation, e.g. substantially perpendicular to the reference surface.
  • the reference surface may also be determined by the processor based on image data. As shown in Fig. 3, if it is determined that the drug delivery device 1 is in a state in which it is not at the desired orientation, instructions to move it to the desired orientation may be communicated to the user. This may include displaying an augmented reality image of the desired orientation in a real-time displayed image of the drug delivery device 1.
  • Orientation of the drug delivery device 1 may relate to an orientation in which a specific part (or parts) of the drug delivery device is visible by the data capture device 3.
  • the specific part of the drug delivery device 1 may be a part (or parts) of the mechanical dispensing means, such as an interface between the part of mecnamcat dispensing means (e.g. plunger) of the drug delivery device 1 and the liquid.
  • the processor may be configured to process images to determine whether the drug delivery device 1 has a desired orientation, e.g. in which the specific part is visible.
  • the processor may be configured to determine the desired orientation in which the specific part is visible based on pre-stored data relating to the drug delivery device 1.
  • instructions to move it to the desired orientation may be communicated to the user. This may include displaying an augmented reality image of the desired orientation in a real-time displayed image of the drug delivery device 1.
  • Initiation of drug delivery by the drug delivery device 1 may relate to pressing a button of an injection mechanism of the device, or initiation of movement of the drug through the drug delivery device. Movement of the drug may be based on the position of a part (or parts) of the mechanical dispensing means, such as an interface between the part of the mechanical dispensing means (e.g. plunger) of the drug delivery device 1 and the liquid.
  • the processor may be configured to process images to determine whether the drug delivery has been initiated. Alternatively, or additionally, the processor may be configured to process acoustic data to determine whether the drug delivery has been initiated, e.g. the sound of a button press. As shown in Fig.
  • instructions to continue administering the drug may be communicated to the user. This may include displaying an augmented reality image of the amount of drug remaining in a real-time displayed image of the drug delivery device 1.
  • drug delivery may refer to the act of the drug containing liquid being dispensed from the drug delivery device and/or the act of the drug containing liquid being administered to the subject. In some cases, dispensing and administering may be the same. However, in other cases, such as when the drug delivery device is not engaged with the subject, the drug may be dispensed but not administered.
  • the drug delivery may refer to drug dispensing and/or drug administration. Information regarding drug administration may be determined based on drug dispensing.
  • the rate of drug delivery by the drug delivery device 1 may be based on the rate ot movement of the drug through the drug delivery device 1.
  • the processor may be configured to process images to determine the rate of drug delivery.
  • This may be based on the position of a part (or parts) of the mechanical dispensing means, such as an interface between the part of the mechanical dispensing means (e.g. plunger) of the drug delivery device 1 and the liquid over time. Based on this the rate of drug delivery may be calculated, e.g. taking into account the type of drug delivery device and the type of drug.
  • the amount of drug delivered by the drug delivery device 1 may be determined based on the amount of movement of the drug through the drug delivery device 1.
  • the processor may be configured to process images to determine rate of amount of drug delivered. This may be based on the position of a part (or parts) of the mechanical dispensing means, such as an interface between the part of the mechanical dispensing means (e.g. plunger) of the drug delivery device 1 and the liquid. Based on this the amount of drug delivered may be calculated, e.g. taking into account the type of drug delivery device and the type of drug. This may be used to verify that the expected does has been provided.
  • the temperature of the drug delivered by the drug delivery device 1 may be determined based on the rate of movement of the drug through the drug delivery device 1.
  • the processor may be configured to process images to determine temperature of the drug delivered. This may be based on the position of a part (or parts) of the mechanical dispensing means, such as an interface between the part of the mechanical dispensing means (e.g. plunger) of the drug delivery device 1 and the liquid over time. Based on this the temperature of the drug may be calculated, e.g. taking into account the type of drug delivery device and the type of drug. The higher the rate of movement, the less viscous the drug and the higher the temperature.
  • Interruption of drug delivery by the drug delivery device 1 may be determined based on whether the rate of drug delivery (e.g. as determined above) substantially changes. For example, if the rate of drug delivery increases, then it may be determined that the drug delivery device has been removed from the subject such that that resistance to the syringe has been lowered. If the rate of drug delivery decreases or stops before the full dose is provided, there may be a problem with the mechanical dispensing means or another factor inhibiting delivery, e.g. a blockage. An end of drug delivery by the drug delivery device 1 may be determined when a full dose is calculated (as above) and/or when at least a part of a mechanical dispensing means reached a predefined end position, e.g.
  • the processor may be configured to process images to determine the end of drug delivery. Alternatively, or additionally, the processor may be configured to process acoustic data to determine the end of drug delivery, e.g. a sound (e.g. click) emitted by the drug delivery device, such as needle retraction. As shown in Fig. 3, if it is determined that the drug delivery device 1 is in a state in which the end of drug delivery is reached, instructions to remove the drug delivery device 1 may be communicated to the user. This may include displaying an augmented reality image of the amount of drug remaining in a real-time displayed image of the drug delivery device 1.
  • the state of the drug delivery device 1 may be determined based on standard image or audio processing techniques that identify specific features in the data indicative of a particular state.
  • the state of the drug delivery device 1 may be determined by machine learning algorithms that are trained to identify the state based on input data, e.g. a machine learning classifier.
  • the machine learning algorithms may be self-learning, e.g. user feedback regarding the state of the drug delivery device 1 may be used to improve the algorithms.
  • the process executed by the processor to provide feedback to the user may be based on learned behaviour of the user. This may be implemented by machine leaning algorithms. For example, if a user performs a particular action the algorithm may learn to pre-empt that action and provide different feedback next time. For example, if a user prematurely removes the drug delivery device, the device will emphasis more on ‘Keep holding’ the next time the user is using the device.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medical Informatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Vascular Medicine (AREA)
  • Primary Health Care (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Pathology (AREA)
  • Computer Networks & Wireless Communication (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • General Business, Economics & Management (AREA)
  • Business, Economics & Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Radiology & Medical Imaging (AREA)
  • Physiology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

L'invention concerne un système pour surveiller l'administration d'un médicament à un sujet par un dispositif d'administration de médicament, le système comprenant : un dispositif de capture de données, séparé du dispositif d'administration de médicament, conçu pour obtenir des données sensorielles concernant le dispositif d'administration de médicament, lorsque le dispositif d'administration de médicament est utilisé ; un processeur conçu pour traiter les données sensorielles afin de déterminer un état du dispositif d'administration de médicament.
PCT/GB2023/052196 2022-08-24 2023-08-23 Système et procédé de surveillance d'administration de médicament WO2024042324A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB2212316.0A GB2623937A (en) 2022-08-24 2022-08-24 System and method
GB2212316.0 2022-08-24

Publications (1)

Publication Number Publication Date
WO2024042324A1 true WO2024042324A1 (fr) 2024-02-29

Family

ID=83902174

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2023/052196 WO2024042324A1 (fr) 2022-08-24 2023-08-23 Système et procédé de surveillance d'administration de médicament

Country Status (2)

Country Link
GB (1) GB2623937A (fr)
WO (1) WO2024042324A1 (fr)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017147202A1 (fr) * 2016-02-22 2017-08-31 West Pharmaceutical Services, Inc. Reconnaissance de l'état d'un dispositif d'administration de médicament
US20200312437A1 (en) * 2017-11-15 2020-10-01 Sanofi System and method for supporting on the use of an injection device
US20200381106A1 (en) * 2019-05-31 2020-12-03 Becton, Dickinson And Company Systems, apparatuses and methods for capturing images of medical condition management events and related equipment with smartphone and related app that processes images to reduce medical errors
US20210280291A1 (en) * 2018-11-28 2021-09-09 Ypsomed Ag Augmented reality for drug delivery devices
US20220122698A1 (en) * 2013-04-12 2022-04-21 Aic Innovations Group, Inc. Apparatus and Method for Recognition of Medication Administration Indicator

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3058973A1 (fr) * 2015-02-19 2016-08-24 Sanofi-Aventis Deutschland GmbH Dispositif supplémentaire pour une fixation amovible à un dispositif d'injection de médicament
WO2018013843A1 (fr) * 2016-07-15 2018-01-18 Common Sensing Inc. Systèmes et procédés de mesure de dose
US11833333B2 (en) * 2017-07-12 2023-12-05 Insuline Medical Ltd Drug tracking device
EP3727522A1 (fr) * 2017-12-21 2020-10-28 Sanofi Détection acoustique d'une utilisation d'un dispositif d'injection
EP3545992A1 (fr) * 2018-03-29 2019-10-02 Tecpharma Licensing AG Estimation d'état pour des systèmes d'administration de médicament

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220122698A1 (en) * 2013-04-12 2022-04-21 Aic Innovations Group, Inc. Apparatus and Method for Recognition of Medication Administration Indicator
WO2017147202A1 (fr) * 2016-02-22 2017-08-31 West Pharmaceutical Services, Inc. Reconnaissance de l'état d'un dispositif d'administration de médicament
US20200312437A1 (en) * 2017-11-15 2020-10-01 Sanofi System and method for supporting on the use of an injection device
US20210280291A1 (en) * 2018-11-28 2021-09-09 Ypsomed Ag Augmented reality for drug delivery devices
US20200381106A1 (en) * 2019-05-31 2020-12-03 Becton, Dickinson And Company Systems, apparatuses and methods for capturing images of medical condition management events and related equipment with smartphone and related app that processes images to reduce medical errors

Also Published As

Publication number Publication date
GB2623937A (en) 2024-05-08
GB202212316D0 (en) 2022-10-05

Similar Documents

Publication Publication Date Title
US10646653B2 (en) Injection device configured to mate with a mobile device
EP3258993B1 (fr) Dispositif supplémentaire pour une fixation amovible à un dispositif d'injection de médicament
JP6685318B2 (ja) 薬剤投与量データ収集
US8231578B2 (en) System and method for sequencing channels in a multi-channel infusion pump
KR101971695B1 (ko) 복약 모니터링 장치 및 방법
US20210280291A1 (en) Augmented reality for drug delivery devices
US20170312457A1 (en) Mobile imaging modality for medical devices
WO2010053702A1 (fr) Procédé de programmation automatique d'une pompe d'infusion
WO2024042324A1 (fr) Système et procédé de surveillance d'administration de médicament
US20220062536A1 (en) Wearable micro-dosing drug delivery device
EP4261833A1 (fr) Guide pour un processus d'administration de médicaments
US11783934B2 (en) Automatic safety adjustment system
US20220379012A1 (en) Infusion device and method with user interface
CN116705231A (zh) 一种输注泵的配置方法及输注设备
KR20190029220A (ko) 주사 장치용 주사액 카트리지 판별 및 관리 시스템

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 23764694

Country of ref document: EP

Kind code of ref document: A1